Q BioMed Inc (QBIO)
0.00
USD |
OTCM |
May 16, 16:00
Q BioMed Cash from Operations (Quarterly): -0.1382M for Feb. 28, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| February 28, 2023 | -0.1382M |
| November 30, 2022 | 2.668M |
| August 31, 2022 | -0.2393M |
| May 31, 2022 | -0.11M |
| February 28, 2022 | -0.3769M |
| November 30, 2021 | -1.560M |
| August 31, 2021 | -0.8405M |
| May 31, 2021 | -1.085M |
| February 28, 2021 | -0.817M |
| November 30, 2020 | -1.472M |
| August 31, 2020 | -1.694M |
| May 31, 2020 | -1.671M |
| February 29, 2020 | -1.397M |
| November 30, 2019 | -1.029M |
| August 31, 2019 | -0.4895M |
| May 31, 2019 | -1.216M |
| February 28, 2019 | -1.371M |
| November 30, 2018 | -1.467M |
| August 31, 2018 | -1.537M |
| Date | Value |
|---|---|
| May 31, 2018 | -1.863M |
| February 28, 2018 | -1.583M |
| November 30, 2017 | -1.661M |
| August 31, 2017 | -1.292M |
| May 31, 2017 | -1.406M |
| February 28, 2017 | -1.225M |
| November 30, 2016 | -0.6768M |
| August 31, 2016 | -0.28M |
| May 31, 2016 | -0.243M |
| February 29, 2016 | -0.3455M |
| November 30, 2015 | -0.0787M |
| August 31, 2015 | -0.0008M |
| May 31, 2015 | -0.0027M |
| February 28, 2015 | -0.0093M |
| November 30, 2014 | -0.0188M |
| August 31, 2014 | -0.0061M |
| May 31, 2014 | -0.0047M |
| February 28, 2014 | -0.0078M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-1.694M
Minimum
Aug 2020
2.668M
Maximum
Nov 2022
-0.7166M
Average
-0.9347M
Median
Cash from Operations (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -1.572M |
| Palatin Technologies Inc | -8.607M |
| iBio Inc | -4.706M |
| Theriva Biologics Inc | -4.881M |
| Oragenics Inc | -1.102M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Financing (Quarterly) | 0.1114M |
| Free Cash Flow | 2.180M |
| Free Cash Flow Per Share (Quarterly) | -0.0013 |